Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Breast Cancer Research and Treatment|October 28, 2019
Molecular determinants of drug response in TNBC cell linesNathan M Merrill, Eric J Lachacz, Nathalie M Vandecan, et al.Scientific Reports|December 20, 2016
Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase SignalingSteven G Allen, Yu-Chih Chen, Julie M Madden, et al.Journal of the American Chemical Society|June 17, 2021
Norstictic Acid Is a Selective Allosteric Transcriptional RegulatorJulie M Garlick, Steven M Sturlis, Paul A Bruno, et al.Neoplasia (New York, N.Y.)|March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancerAnbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.The Journal of Biological Chemistry|April 30, 2016
RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer CellsMichelle L Wynn, Joel A Yates, Charles R Evans, et al.Journal of Cell Science|March 29, 2018
Loss of PTEN promotes formation of signaling-capable clathrin-coated pitsLuciana K Rosselli-Murai, Joel A Yates, Sei Yoshida, et al.Neoplasia (New York, N.Y.)|May 14, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4Daniel J Coleman, David A Sampson, Archana Sehrawat, et al.Advanced Nanobiomed Research|May 26, 2023
Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasisTrisha M Westerhof, Benjamin A Yang, Nathan M Merill, et al.JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.Pageof 3